A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Maxitrol Indications, Dosage, Storage, Stability - Neomycin; Polymyxin B and Dexamethasone
Maxitrol Indications, Dosage, Storage, Stability - Neomycin; Polymyxin B and Dexamethasone
INDICATIONS
For steroid-responsive inflammatory
ocular conditions for
which a corticosteroid is indicated and where bacterial infection
or a risk of bacterial
ocular infection exists.
Ocular steroids are indicated in inflammatory
conditions of the palpebral and bulbar
conjunctiva, cornea,
and anterior segment
of the globe where the inherent
risk of steroid
use in certain infective conjunctivitides is accepted to obtain
a diminution in edema
and inflammation. They are also indicated in chronic
anterior uveitis
and corneal injury from
chemical, radiation or thermal
burns; or penetration
of foreign bodies.
The use of a combination drug
with an anti- infective component
is indicated where the risk
of infection is high
or where there is an expectation that potentially dangerous numbers
of bacteria will
be present in the eye.
The particular anti-infective drug
in this product is active
against the following common bacterial eye
pathogens: Staphylococcus aureus, Escherichia coli, Haemophilus
influenzae, Klebsiella/ Enterobacterspecies, Neisseria species,
and Pseudomonas aeruginosa.
This product does not
provide adequate coverage against: Serratia marcescens and
Streptococci, including Streptococcus pneumoniae.
DOSAGE AND ADMINISTRATION
One to two drops topically in the conjunctival sac(s). In
severe disease, drops may be used hourly, being tapered to discontinuation
as the inflammation subsides. In
mild disease, drops
may be used up to four to six times daily.
Not more than 20 mL should be prescribed initially and the prescription
should not be refilled without further evaluation
as outlined in PRECAUTIONS.
HOW SUPPLIED
Sterile ophthalmic
suspension in 5 mL
plastic DROP-TAINER®
dispenser (NDC 61314-630-06).
Storage: Store at 8°- 27° C ( 46°- 80°
F).
top
